<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from unaudited financial statements contained in Form 10-Q for the Quarter ending June 30, 1995 and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-END> JUN-30-1995 <CASH> 1,348,394 <SECURITIES> 0 <RECEIVABLES> 1,306,579 <ALLOWANCES> 166,619 <INVENTORY> 541,379 <CURRENT-ASSETS> 3,345,375 <PP&E> 3,540,114 <DEPRECIATION> 2,116,747 <TOTAL-ASSETS> 6,255,826 <CURRENT-LIABILITIES> 1,455,157 <BONDS> 0 <COMMON> 11,876,285 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> (7,603,812) <TOTAL-LIABILITY-AND-EQUITY> 6,255,826 <SALES> 5,306,590 <TOTAL-REVENUES> 5,306,590 <CGS> 4,031,735 <TOTAL-COSTS> 4,031,735 <OTHER-EXPENSES> 1,459,542<F1> <LOSS-PROVISION> 30,006 <INTEREST-EXPENSE> 28,338 <INCOME-PRETAX> (187,076) <INCOME-TAX> 0 <INCOME-CONTINUING> (187,076) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (187,076) <EPS-PRIMARY> (0.03) <EPS-DILUTED> (0.03) <FN> <F1>Other expenses include $961,480 in general and administrative expense and $498,062 in research and development expense. </FN>